CVE-2001-0991
Cross-site scripting vulnerability in Proxomitron Naoko-4 BetaFour and earlier allows remote attackers to execute arbitrary script on other clients via an incorrect URL containing the malicious script, which is printed back in an error message.
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (7.10%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Cross-site scripting vulnerability in Proxomitron Naoko-4 BetaFour and earlier allows remote attackers to execute arbitrary script on other clients via an incorrect URL containing the malicious script, which is printed back in an error message.
- CVSS 2.0
- 7.5 HIGHAV:N/AC:L/Au:N/C:P/I:P/A:P
- EPSS
- 7.10% probability · 94th percentile
- CISA KEV
- Not listed
- Affected
- scott r. lemmon/proxomitron naoko-4
- Source
- cve@mitre.org
References
- http://www.securityfocus.com/archive/1/198954Patch, Vendor Advisory
- http://www.securityfocus.com/bid/3087Exploit, Patch, Vendor Advisory
- https://exchange.xforce.ibmcloud.com/vulnerabilities/6887
- http://www.securityfocus.com/archive/1/198954Patch, Vendor Advisory
- http://www.securityfocus.com/bid/3087Exploit, Patch, Vendor Advisory
- https://exchange.xforce.ibmcloud.com/vulnerabilities/6887
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.